Literature DB >> 18057297

Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab.

Ravi Murthy1, Cathy Eng, Sunil Krishnan, David C Madoff, Amit Habbu, Sara Canet, Marshall E Hicks.   

Abstract

Yttrium-90 microspheres have been recently approved by the Food and Drug Administration and have become available to physicians in the United States for the treatment of hepatic neoplasia. Published results regarding the benefits of 90Y radioembolotherapy within the rapidly evolving landscape of systemic therapies for advanced unresectable colorectal cancer are limited. In that context, outcomes in patients who have received the recently approved biologic agents bevacizumab and cetuximab in addition to chemotherapy are unknown. This report briefly describes the authors' treatment experience with this cohort of patients.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18057297     DOI： 10.1016/j.jvir.2007.08.015

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN： 1051-0443            Impact factor:   3.464


  9 in total

Review 1.  Radioembolization for primary and metastatic liver cancer.

Authors:  Khairuddin Memon; Robert J Lewandowski; Laura Kulik; Ahsun Riaz; Mary F Mulcahy; Riad Salem
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

Review 2.  Chemoembolization and radioembolization for metastatic disease to the liver: available data and future studies.

Authors:  Khairuddin Memon; Robert J Lewandowski; Ahsun Riaz; Riad Salem
Journal:  Curr Treat Options Oncol       Date:  2012-09

3.  Sustained safety and efficacy of extended-shelf-life (90)Y glass microspheres: long-term follow-up in a 134-patient cohort.

Authors:  Robert J Lewandowski; Jeet Minocha; Khairuddin Memon; Ahsun Riaz; Vanessa L Gates; Robert K Ryu; Kent T Sato; Reed Omary; Riad Salem
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-10       Impact factor: 9.236

Review 4.  Pancreatic neuroendocrine tumors.

Authors:  Shailesh V Shrikhande; Bhawna Sirohi; Mahesh Goel; Savio G Barreto
Journal:  Indian J Gastroenterol       Date:  2012-10-03

Review 5.  Interventional Treatment of Hepatic Metastases from Colorectal Cancer.

Authors:  Patrick D Sutphin; Suvranu Ganguli
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

Review 6.  A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases.

Authors:  Akshat Saxena; Lourens Bester; Leonard Shan; Marlon Perera; Peter Gibbs; Baerbel Meteling; David L Morris
Journal:  J Cancer Res Clin Oncol       Date:  2013-12-07       Impact factor: 4.553

Review 7.  Liver metastases from colorectal cancer: radioembolization with systemic therapy.

Authors:  Nils H Nicolay; David P Berry; Ricky A Sharma
Journal:  Nat Rev Clin Oncol       Date:  2009-11-03       Impact factor: 66.675

8.  Radioembolization for hepatocellular carcinoma using TheraSphere®.

Authors:  Safiyya Mohamed Ali
Journal:  Saudi J Gastroenterol       Date:  2011 May-Jun       Impact factor: 2.485

Review 9.  Side effects of yttrium-90 radioembolization.

Authors:  Ahsun Riaz; Rafia Awais; Riad Salem
Journal:  Front Oncol       Date:  2014-07-29       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.